$MNST

Morgan Stanley unveils key Monster stock price prediction

Morgan Stanley reiterated an Overweight rating and $103 price target on Monster Beverage (MNST), citing new product launches. Morgan said new items rose to nearly 15% of Monster’s US retail sales from about 3.5% end-2025 and zero in September. Monster reported Q1 2026 net sales up 26.9% to $2.35B and authorized a $500M buyback; gross margin slipped to 55% from 56.5%.

Original reporting
Published Jul 5, 2026, 1:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 5, 2026, 1:48 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley unveils key Monster stock price prediction — source image
Decision brief

The 30-second read

$MNSTBullishMed
01

Why it matters

The actionable element is the reiterated Overweight rating and $103 price target, supported by quantified product contribution to US retail sales and a reminder of margin pressure.

02

Market read

Traders may use the note to reassess the probability of continued product-driven sales momentum versus margin headwinds.

03

What to watch

Gross margin slipped to 55% from 56.5% year-over-year, and the article attributes it to faster overseas growth—if that mix persists, upside may be capped despite sales growth.

Relevance 7/10Novelty 5/10Timing: today/this week as the fresh Morgan Stanley note reiterates a $103 PT and Overweight stance

Background

Morgan Stanley says it has made the same call twice in the past two months and now points to evidence from Monster’s expanding product lineup.

Company-level read

Ticker impact

$MNSTBullishMedium confidence
Context

Morgan Stanley reiterated Overweight and a $103 price target on Monster Beverage, citing new products reaching ~15% of US sales.

Expected impact

Near-term: modest positive bias as traders may reprice expectations around product-driven sales durability; follow-through depends on upcoming earnings and margin trajectory.

Evidence & confidence

The article provides a specific analyst action (reiterated rating and PT) plus quantified product contribution (~15% of US sales) and a margin caveat (gross margin down).

Market effects

Supports the broader beverage/energy-drink narrative that innovation-led mix shifts can drive share gains, potentially influencing read-across to peers’ product-cycle expectations.

Highlights international growth as a driver (international sales ~44.9% of revenue), which may keep attention on overseas demand and margin structure.

Limited—primarily a single-name catalyst, though it reinforces global consumer packaged beverage innovation as a theme.

Counterpoint

The ~15% sales contribution could still be partially promotional/limited-time; if velocity fades, the durability assumption may weaken.

Key entities

  • Monster Beverage

    Energy drink maker whose new product lineup is claimed to be driving ~15% of US sales and is the subject of the analyst reiteration.

  • Morgan Stanley

    Reiterated Overweight rating and $103 price target, citing product mix evidence and recent quarterly performance.

Related articles

$PEPMed

International Business: India ‘won’t extend’ energy drink label deadline

India’s food safety regulator FSSAI will not extend a 90-day deadline to remove “energy drink” or similar labels from high-caffeine beverages, a government source said. PepsiCo, Red Bull, Monster Beverage and Reliance are seeking up to one year, citing inventory and pending imports. FSSAI says the term breaches rules and states can sell existing stock in 60-90 days.

$MNSTMed

Morgan Stanley Lifts Monster Beverage Target to $110, Sees More Upside Ahead — BigGo Finance

Morgan Stanley raised its Monster Beverage (MNST) price target to $110 from $103 and reiterated an Overweight rating, implying about 9% upside versus current levels, according to the bank. FactSet shows analysts average an Overweight rating and a mean target of $100.70. Investors may look to upcoming quarterly results for volume, pricing, and margin trends.

$MNSTMed

Monster (NASDAQ:MNST) Surprises With Q2 CY2026 Sales

Monster Beverage (NASDAQ: MNST) reported Q2 CY2026 sales of $2.54 billion, up 20.2% year on year, topping Wall Street revenue expectations by 4.1%. Non-GAAP profit was $0.60 per share, about 3% above consensus. The article notes trailing 12-month revenue of $9.22 billion and a free cash flow margin averaging 24.4% over two years.

$MNSTMedAI 9/10

Monster Beverage Corp (MNST): Results of Operations and Financial Condition

Monster Beverage Corp (MNST) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622396d1_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Investor Relations Strategic Public Relations PondelWilkinson Inc. 2945 Townsgate Road, Suite 200 Westlake Village, CA 91361 T (310) 279 5980 W www.pondel.com CONTACTS: NEWS RELEASE Mark Astrachan SVP, Investor Relations